Puma Biotechnology Inc has a share price target of US$ 4, revenue growth forecast of -5.3%, and profit growth estimate of -38.1% for FY25, based on top 3 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature